Wuhan Keqian Biology Co.,Ltd.’s Net Profit Dropped 26.6% in First Three Quarters of 2022

Wuhan Keqian Biology Co.,Ltd. (武汉科前生物股份有限公司) (688526.SH) reported a net profit of 283.2 million yuan in the first three quarters of 2022, down 26.6% year-on-year.

Meanwhile, the company posted 686.5 million yuan in revenue, down 11.5% year-on-year.

At the end of the reporting period, it had 4.1 billion yuan in total assets and 747.7 million yuan in total liabilities, with a liability-to-asset ratio of 18.2%.